Inventor · disambiguated record
Jumpei Aida
Also filed as: AIDA JUMPEI
12 granted patents·1 pending application·51 citations·filing 2013–2021
87Inventor score
Top patents by PatentIndex Score
13 records- 0193US10610520B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 0293US10323026B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 18, 2019·20 cites·10 claims
- 0389US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0486US10106556B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Oct 23, 2018·8 cites·20 claims
- 0585US11186565B2Aromatic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 30, 2021·3 cites·10 claims
- 0684US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 0776US9624170B24-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·3 cites·16 claims
- 0870US9776962B2Aromatic compounds with GPR40 agonistic activityTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 3, 2017·2 cites·16 claims
- 0964US2023002318A1Heterocyclic nmda antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1048US10968231B2Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disordersTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 6, 2021·0 cites·10 claims
- 1144US9199963B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Granted Dec 1, 2015·0 cites·20 claims
- 1243US11414422B2Substituted pyrido[4,3-b]indoles and azepino[4,5-b]indoles as inhibitors of cGASUNIV ROCKEFELLER·Filed 2019·Granted Aug 16, 2022·0 cites·19 claims
- 1338US9365540B2Benzimidazole derivatives as MCH receptor antagonistsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jun 14, 2016·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Jumpei Aida files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →